These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

738 related items for PubMed ID: 15540510

  • 1. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
    Ramos-Casals M, Campoamor MT, Chamorro A, Salvador G, Segura S, Botero JC, Yagüe J, Cervera R, Ingelmo M, Font J.
    Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
    [Abstract] [Full Text] [Related]

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 3. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 4. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L, Kontic M, Djokovic A, Marisavljevic D, Ilijevski N, Stanisavljevic N, Mikovic Z, Petkovic M, Kovcin V.
    Clin Exp Rheumatol; 2013 Aug; 31(2):234-42. PubMed ID: 23306109
    [Abstract] [Full Text] [Related]

  • 5. [Clinical characteristics of 37 antiphospholipid syndrome patients complicated by autoimmune hemolytic anemia].
    Zhang JT, Qi WT, Zhou YZ, Huang C, Zhao JL, Li MT, Zeng XF.
    Zhonghua Nei Ke Za Zhi; 2023 Feb 01; 62(2):147-155. PubMed ID: 36740405
    [Abstract] [Full Text] [Related]

  • 6. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U, Yayla ME, Ateş A, Okatan İE, Yurteri EU, Torgutalp M, Keleşoğlu ABD, Turgay TM, Kınıklı G.
    Lupus; 2018 Apr 01; 27(4):665-669. PubMed ID: 29050535
    [Abstract] [Full Text] [Related]

  • 7. Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome.
    Pérez D, Stojanovich L, Naranjo L, Stanisavljevic N, Bogdanovic G, Serrano M, Serrano A.
    Front Immunol; 2018 Apr 01; 9():2644. PubMed ID: 30524428
    [Abstract] [Full Text] [Related]

  • 8. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct 01; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 9. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
    Gómez-Puerta JA, Martín H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ, Hughes GRV, Khamashta MA.
    Medicine (Baltimore); 2005 Jul 01; 84(4):225-230. PubMed ID: 16010207
    [Abstract] [Full Text] [Related]

  • 10. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
    Savelli SL, Roubey RAS, Kitzmiller KJ, Zhou D, Nagaraja HN, Mulvihill E, Barbar-Smiley F, Ardoin SP, Wu YL, Yu CY.
    Front Immunol; 2019 Jul 01; 10():885. PubMed ID: 31134052
    [Abstract] [Full Text] [Related]

  • 11. Immunological abnormalities in primary APS evolving into SLE: 6 years follow-up in women with repeated pregnancy loss.
    Carbone J, Orera M, Rodríguez-Mahou M, Rodríguez-Pérez C, Sánchez-Ramón S, Seoane E, Rodríguez JJ, Zabay JM, Fernández-Cruz E.
    Lupus; 1999 Jul 01; 8(4):274-8. PubMed ID: 10413205
    [Abstract] [Full Text] [Related]

  • 12. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
    Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A, Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi T, Willis R, Zuily S, Tektonidou MG, AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Investigators.
    Arthritis Care Res (Hoboken); 2019 Jan 01; 71(1):134-141. PubMed ID: 29669399
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
    Singh NK, Agrawal A, Singh MN, Kumar V, Godhra M, Gupta A, Yadav DP, Usha, Singh RG, Singh TB.
    J Assoc Physicians India; 2013 Sep 01; 61(9):623-6. PubMed ID: 24772699
    [Abstract] [Full Text] [Related]

  • 14. Lupus pregnancy. II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient.
    Lockshin MD, Harpel PC, Druzin ML, Becker CG, Klein RF, Watson RM, Elkon KB, Reinitz E.
    Arthritis Rheum; 1985 Jan 01; 28(1):58-66. PubMed ID: 3917671
    [Abstract] [Full Text] [Related]

  • 15. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A, Kickler TS, Petri M.
    J Rheumatol; 2006 Sep 01; 33(9):1775-9. PubMed ID: 16960938
    [Abstract] [Full Text] [Related]

  • 16. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
    Garabet L, Gilboe IM, Mowinckel MC, Jacobsen AF, Mollnes TE, Sandset PM, Jacobsen EM.
    Scand J Immunol; 2016 Aug 01; 84(2):95-9. PubMed ID: 27135178
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus.
    Li H, Lin S, Yang S, Chen L, Zheng X.
    Clin Rheumatol; 2015 Mar 01; 34(3):471-7. PubMed ID: 25597615
    [Abstract] [Full Text] [Related]

  • 18. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients.
    Cervera R, García-Carrasco M, Font J, Ramos M, Reverter JC, Muñoz FJ, Miret C, Espinosa G, Ingelmo M.
    Clin Exp Rheumatol; 1997 Mar 01; 15(4):361-5. PubMed ID: 9272295
    [Abstract] [Full Text] [Related]

  • 19. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus.
    Clowse ME, Magder LS, Petri M.
    J Rheumatol; 2011 Jun 01; 38(6):1012-6. PubMed ID: 21406496
    [Abstract] [Full Text] [Related]

  • 20. Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients.
    Dima A, Caraiola S, Jurcut C, Balanescu E, Balanescu P, Ramba D, Badea C, Pompilian V, Ionescu R, Baicus A, Baicus C, Dan GA.
    Rom J Intern Med; 2015 Jun 01; 53(4):321-8. PubMed ID: 26939208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.